Personal Group reports 11% revenue growth, lifts dividend 41%

Adjusted EBITDA rose 22% to £12.1m for the year ended Dec 31, 2025, beating the company's view of market expectations of £11.6m. Revenue increased 11% to £48.4m, profit before tax climbed 23% to £8.4m and basic EPS grew 32% to 23.3p; the final dividend was 15.1p, taking the full-year payout to 23.3p (+41%). Annualized recurring revenue reached £48.6m (+12%) with >90% of revenue recurring, cash of £29.0m and no debt, while cash generated from operations fell to £9.9m from £11.4m.

Analysis

Small-cap employee-benefits / insurance hybrids can re-rate sharply when investors assign a SaaS-style multiple to their recurring cash flows; the premium comes only if retention and cohort-level expansion are demonstrably stable rather than a sequence of one-off client wins. Distribution partnerships and channel access are the scalable lever — they lower CAC and accelerate ARR visibility, but they also create concentration risk if a few distribution partners or large clients drive new sales.

The chief non-linear risks are insurance-cycle shocks and margin resets: adverse claims experience or a reinsurance price move can convert a growth story into a capital story within a single reporting cycle. Interest-rate volatility also matters because it changes the present value of long-duration, contractually-stepped revenue and influences management’s choices on buybacks versus reinvestment; both will be obvious focal points at the upcoming investor event.

For trade timing, treat the next reporting / webinar as a binary catalyst window (days–weeks) and the re-rating thesis as a 6–12 month call dependent on evidence of sustained net retention and continued low CAC from partners. The consensus risk is the comfortable habit of valuing the business purely as SaaS; the contrarian read is that a single adverse insurance quarter would reprice the stock materially faster than incremental ARR beats can re-rate it up.

Key Decisions for Investors

• Long PGH.L equity (size 2–4% of portfolio). Timeframe 6–12 months. Rationale: buy on continued ARR momentum and any commitment to capital returns; target +35% upside if multiple re-rating occurs. Risk management: stop-loss at -15% or sell on any quarter that shows a clear increase in claims or a step-down in operating cash generation.
• Event trade around investor webinar: buy a short-term position (7–14 days) into the webinar to capture guidance upside; take profits on any >15% pop within 48 hours post-event. Keep size small (1%–2%) to limit exposure to typical post-event volatility.
• Risk-managed options play if options market exists: buy a 9–12 month call spread (debit-limited) to cap downside while retaining upside participation — construct to achieve ~3:1 upside/downside at expected move. If options illiquid, substitute by buying the equity and hedging with a 6-month protective put to limit tail risk.
• Monitor for M&A: if management signals accelerated cross-sell or partner exclusivity, shift to overweight quickly; conversely, if commentary centers on one-off large client wins without cohort improvement, reduce exposure and rotate into higher-quality SaaS peers.